Navigation Links
Stem Cell Research Offers Clues About Schizophrenia
Date:9/12/2014

FRIDAY, Sept. 12, 2014 (HealthDay News) -- New research involving stem cells may provide clues about the chemical basis for schizophrenia, scientists report.

Brain cells of people with this chronic and disabling brain disorder give off higher amounts of three neurotransmitters linked to a range of psychiatric disorders, researchers found. Neurotransmitters are chemicals that trigger or block the transmission of electrical signals in the brain.

Although the cause of schizophrenia remains unknown and there is no cure, the study authors suggested their findings shed new light on the chemical basis of the disorder. Ultimately, they believe the study results could help scientists treat patients with schizophrenia more effectively.

"The study provides new insights into neurotransmitter mechanisms in schizophrenia that can lead to new drug targets and [treatments]," study senior author Vivian Hook, a professor with Skaggs School of Pharmacy at the University of California, San Diego, School of Medicine.

"All behavior has a neurochemical basis in the brain. This study shows that it is possible to look at precise chemical changes in neurons of people with schizophrenia," she said in a university news release.

In conducting the study, published online Sept. 11 in Stem Cell Reports, researchers created working brain cells using stem cell technology. The brain cells were activated to secrete neurotransmitters.

The brain cells taken from people with schizophrenia gave off higher amounts of three neurotransmitters: dopamine, norepinephrine and epinephrine.

The researchers also found that for people with schizophrenia, more brain cells were focused on production of tyrosine hydroxylase -- an initial step in the production of dopamine. They noted that both norepinephrine and epinephrine are made from dopamine.

Potentially, the findings could help doctors evaluate the severity of a patient's disease, identify different types of schizophrenia and determine which treatments would be most effective.

"It is very powerful to be able to see differences in neurons derived from individual patients," Hook concluded.

The U.S. National Institutes of Health provided partial funding for the study.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

SOURCE: University of California, San Diego, news release, Sept. 11, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Laparoscopic Devices Market 2014-2018 Global Forecasts and Analysis in New Research Report at ReportsnReports.com
2. World BoPET Market: Biaxially-oriented Polyethylene Terephthalate 2014 Analysis Now Available at DeepResearchReports.com
3. Diabetes researchers find faster way to create insulin-producing cells
4. Sodium Hydroxide Market & Sodium Fluoride Industry (Global, China) Research Analysis Now at DeepResearchReports.com
5. Researchers make scientific history with new cellular connection
6. Dartmouth research links genetic mutation and melanoma progression
7. Nova Southeastern University researcher receives a nearly $2 million grant
8. Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research
9. Researchers Probe Molecular Cause for Glaucoma
10. Global Skincare Devices Market Is Expected To Be Worth $12,799.5 Million By 2020: Grand View Research, Inc
11. Even small stressors may be harmful to mens health, new OSU research shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem Cell Research Offers Clues About Schizophrenia
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: